Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

739 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Current therapeutic strategy for rheumatoid arthritis].
Wollenhaupt J, Alten R, Burkhardt H, Edelmann E, Gromnica-Ihle E, Krause A, Krüger K, Manger B, Lorenz H, Müller-Ladner U, Nüsslein H, Pott HG, Tony H, Schneider M. Wollenhaupt J, et al. Among authors: lorenz h. MMW Fortschr Med. 2006 Oct 19;148(42):38-42; quiz 43. MMW Fortschr Med. 2006. PMID: 17621798 German.
German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.
Albrecht K, Krüger K, Wollenhaupt J, Alten R, Backhaus M, Baerwald C, Bolten W, Braun J, Burkhardt H, Burmester GR, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Kuipers J, Krause A, Lorenz HM, Manger B, Nüßlein H, Pott HG, Rubbert-Roth A, Schneider M, Specker C, Schulze-Koops H, Tony HP, Wassenberg S, Müller-Ladner U; German Society of Rheumatology. Albrecht K, et al. Among authors: lorenz hm. Rheumatol Int. 2014 Jan;34(1):1-9. doi: 10.1007/s00296-013-2848-3. Epub 2013 Aug 14. Rheumatol Int. 2014. PMID: 23942828 Review.
Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status.
Hagen M, Englbrecht M, Haschka J, Reiser M, Kleyer A, Hueber A, Manger B, Figueiredo C, Cobra JF, Tony HP, Finzel S, Kleinert S, Wendler J, Schuch F, Ronneberger M, Feuchtenberger M, Fleck M, Manger K, Ochs W, Lorenz HM, Nüsslein H, Alten R, Henes J, Krüger K, Schett G, Rech J. Hagen M, et al. Among authors: lorenz hm. J Rheumatol. 2019 May;46(5):460-466. doi: 10.3899/jrheum.180028. Epub 2018 Dec 1. J Rheumatol. 2019. PMID: 30504510 Clinical Trial.
[Criteria for the authorization of training in medical specialist competence in internal medicine and rheumatology-A position paper of the German Society for Rheumatology and Clinical Immunology].
Pfeil A, Fleck M, Aringer M, Baraliakos X, Ernst D, Haase I, Hillebrecht C, Hoyer BF, Keyßer G, Kötter I, Krause A, Krusche M, Lorenz HM, Proft F, Schuch F, Vossen D, Voormann A, Wagner U, Wollenhaupt J, Specker C; Vorstand der Deutschen Gesellschaft für Rheumatologie und Klinische Immunologie; Kommission Fort- und Weiterbildung der Deutschen Gesellschaft für Rheumatologie und Klinische Immunologie. Pfeil A, et al. Among authors: lorenz hm. Z Rheumatol. 2024 Dec 12. doi: 10.1007/s00393-024-01598-5. Online ahead of print. Z Rheumatol. 2024. PMID: 39666002 Review. German.
A systematic assessment of robustness in CNS safety pharmacology.
Reiber M, Stirling H, Ahuis TP, Arias W, Aulehner K, Dreßler U, Kas MJH, Kela J, Kerker K, Kuosmanen T, Lorenz H, Pennington AT, von Rüden EL, Schauerte H, Seiffert I, Talbot SR, Torturo C, Virtanen S, Waldron AM, Ramboz S, Potschka H. Reiber M, et al. Among authors: lorenz h. Br J Pharmacol. 2025 Feb;182(3):530-545. doi: 10.1111/bph.17358. Epub 2024 Oct 10. Br J Pharmacol. 2025. PMID: 39389585
739 results